Reference SummaryDeringer MK, J Natl Cancer Inst 1959;22():995-1002
Title |
Occurrence of tumors, particularly mammary tumors, in agent-free strain C3HeB mice | ||||||||||||||
Authors |
Deringer MK | ||||||||||||||
Journal |
J Natl Cancer Inst | ||||||||||||||
Volume |
22 | ||||||||||||||
Issue |
|||||||||||||||
Year |
1959 | ||||||||||||||
Pages |
995-1002 | ||||||||||||||
Abstract |
|||||||||||||||
Links |
J:24689 – MGI References 13655075 – National Library of Medicine/PubMed |
||||||||||||||
Strain Notes
|
Strain | Model Name | Treatment Agent(s) | Organ Affected | Frequency | Model Details |
---|---|---|---|---|---|
C3HeB/De | Adrenal gland - Cortex adenoma |
|
Adrenal gland - Cortex |
1.0 |
|
C3HeB/De | Adrenal gland - Cortex adenoma | Adrenal gland - Cortex |
4.8 |
||
C3HeB/De | Adrenal gland - Medulla pheochromocytoma | Adrenal gland - Medulla |
1.2 |
||
C3HeB/De | Blood vessel hemangioendothelioma | Blood vessel |
1.2 - 5.2 |
||
C3HeB/De | Blood vessel hemangioendothelioma |
|
Blood vessel |
3.1 |
|
C3HeB/De | Eye - Harderian gland tumor | Eye - Harderian gland |
4.8 |
||
C3HeB/De | Kidney carcinoma |
|
Kidney |
1.0 |
|
C3HeB/De | Leukocyte - Lymphocyte - B-lymphocyte - Plasma cell tumor | Leukocyte - Lymphocyte - B-lymphocyte - Plasma cell |
1.2 |
||
C3HeB/De | Leukocyte - Lymphocyte lymphohematopoietic neoplasm | Leukocyte - Lymphocyte |
1.0 |
||
C3HeB/De | Leukocyte - Lymphocyte lymphohematopoietic neoplasm |
|
Leukocyte - Lymphocyte |
1.0 |
|
C3HeB/De | Leukocyte - Lymphocyte reticulum cell neoplasm, type A | Leukocyte - Lymphocyte |
0.6 - 2.0 |
||
C3HeB/De | Leukocyte - Lymphocyte reticulum cell neoplasm, type A |
|
Leukocyte - Lymphocyte |
2.0 |
|
C3HeB/De | Leukocyte - Lymphocyte reticulum cell neoplasm, type B | Leukocyte - Lymphocyte |
1.9 |
||
C3HeB/De | Leukocyte - Lymphocyte reticulum cell neoplasm, type B |
|
Leukocyte - Lymphocyte |
1.0 |
|
C3HeB/De | Liver hepatoma | Liver |
30 - 90 |
||
C3HeB/De | Liver hepatoma |
|
Liver |
55 |
|
C3HeB/De | Lung tumor | Lung |
3.7 - 24 |
||
C3HeB/De | Lung tumor |
|
Lung |
10 |
|
C3HeB/De | Mammary gland adenoacanthoma | Mammary gland |
17 - 28 |
||
C3HeB/De | Mammary gland adenocarcinoma - type A | Mammary gland |
17 - 26 |
||
C3HeB/De | Mammary gland adenocarcinoma - type A |
|
Mammary gland |
10 |
|
C3HeB/De | Mammary gland adenocarcinoma - type B | Mammary gland |
4.0 - 28 |
||
C3HeB/De | Mammary gland adenocarcinoma - type B |
|
Mammary gland |
12 |
|
C3HeB/De | Mammary gland tumor | Mammary gland |
4.0 - 74 |
||
C3H/He | Mammary gland tumor |
|
Mammary gland |
94 |
|
C3HeB/De | Mammary gland tumor |
|
Mammary gland |
22 |
|
C3Hf/He | Mammary gland tumor | Mammary gland |
2 - 63 |
||
C3Hf/He | Mammary gland tumor |
|
Mammary gland |
20 |
|
C3Hf/An | Mammary gland tumor | Mammary gland |
3 - 27 |
||
C3Hff/He | Mammary gland tumor | Mammary gland |
29 |
||
C3Hf/2He | Mammary gland tumor | Mammary gland |
51 |
||
C3Hf/He | Mammary gland tumor |
|
Mammary gland |
37 - 71 |
|
C3HeB/De | Mammary gland tumor |
|
Mammary gland |
61 - 69 |
|
C3HeB/De | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
1.2 - 7.1 |
||
C3HeB/De | Mesodermal cell/mesoblast sarcoma | Uterus |
3.0 |
||
C3HeB/De | Mesodermal cell/mesoblast sarcoma |
|
Mesodermal cell/mesoblast |
4.1 |
|
C3HeB/De | Myoepithelial cell myoepithelioma | Myoepithelial cell |
1.2 |
||
C3HeB/De | Ovary - Granulosa cell tumor | Ovary - Granulosa cell |
13 - 23 |
||
C3HeB/De | Ovary adenoma - tubular | Ovary |
14 - 25 |
||
C3HeB/De | Ovary luteoma | Ovary |
0.6 - 2.0 |
||
C3HeB/De | Ovary tumor | Ovary |
1.2 |
||
CE/Wy | Ovary tumor | Ovary |
33 |
||
CE/WyDi | Ovary tumor | Ovary |
52 |
||
C3Hf/He | Ovary tumor | Ovary |
5.0 - 10.0 |
||
C3HeB/De | Ovary tumor - mixed | Ovary |
0.6 - 2.0 |
||
C3HeB/De | Skin papilloma | Skin |
0.6 |
||
C3HeB/De | Uterus polyp | Uterus |
1.2 - 4.0 |
||
C3HeB/De | (Unspecified organ) squamous cell carcinoma | (Unspecified organ) |
0.6 |